These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 34305404)

  • 1. Targeting Neuroinflammation via Purinergic P2 Receptors for Disease Modification in Drug-Refractory Epilepsy.
    Engel T; Smith J; Alves M
    J Inflamm Res; 2021; 14():3367-3392. PubMed ID: 34305404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATPergic signalling during seizures and epilepsy.
    Engel T; Alves M; Sheedy C; Henshall DC
    Neuropharmacology; 2016 May; 104():140-53. PubMed ID: 26549853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Context-Specific Switch from Anti- to Pro-epileptogenic Function of the P2Y
    Alves M; De Diego Garcia L; Conte G; Jimenez-Mateos EM; D'Orsi B; Sanz-Rodriguez A; Prehn JHM; Henshall DC; Engel T
    J Neurosci; 2019 Jul; 39(27):5377-5392. PubMed ID: 31048325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and function of the metabotropic purinergic P2Y receptor family in experimental seizure models and patients with drug-refractory epilepsy.
    Alves M; Gomez-Villafuertes R; Delanty N; Farrell MA; O'Brien DF; Miras-Portugal MT; Hernandez MD; Henshall DC; Engel T
    Epilepsia; 2017 Sep; 58(9):1603-1614. PubMed ID: 28733972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Metabotropic Purinergic P2Y Receptor Family as Novel Drug Target in Epilepsy.
    Alves M; Beamer E; Engel T
    Front Pharmacol; 2018; 9():193. PubMed ID: 29563872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Expression of the Metabotropic P2Y Receptor Family in the Cortex Following Status Epilepticus and Neuroprotection
    Alves M; Smith J; Engel T
    Front Pharmacol; 2019; 10():1558. PubMed ID: 32009961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analyzing the Role of the P2X7 Receptor in Epilepsy.
    Alves M; de Diego-Garcia L; Engel T
    Methods Mol Biol; 2022; 2510():367-387. PubMed ID: 35776337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Purinergic P2X7 Receptor as a Target for Adjunctive Treatment for Drug-Refractory Epilepsy.
    Thakku Sivakumar D; Jain K; Alfehaid N; Wang Y; Teng X; Fischer W; Engel T
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purinergic receptors in embryonic and adult neurogenesis.
    Oliveira Á; Illes P; Ulrich H
    Neuropharmacology; 2016 May; 104():272-81. PubMed ID: 26456352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATP and adenosine-Two players in the control of seizures and epilepsy development.
    Beamer E; Kuchukulla M; Boison D; Engel T
    Prog Neurobiol; 2021 Sep; 204():102105. PubMed ID: 34144123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P2 purinergic receptors signal to STAT3 in astrocytes: Difference in STAT3 responses to P2Y and P2X receptor activation.
    Washburn KB; Neary JT
    Neuroscience; 2006 Oct; 142(2):411-23. PubMed ID: 16905269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond Seizure Control: Treating Comorbidities in Epilepsy via Targeting of the P2X7 Receptor.
    Gil B; Smith J; Tang Y; Illes P; Engel T
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P2 receptor signaling in neurons and glial cells of the central nervous system.
    Köles L; Leichsenring A; Rubini P; Illes P
    Adv Pharmacol; 2011; 61():441-93. PubMed ID: 21586367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ATP-Gated P2X7 Receptor As a Target for the Treatment of Drug-Resistant Epilepsy.
    Beamer E; Fischer W; Engel T
    Front Neurosci; 2017; 11():21. PubMed ID: 28210205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient P2X7 Receptor Antagonism Produces Lasting Reductions in Spontaneous Seizures and Gliosis in Experimental Temporal Lobe Epilepsy.
    Jimenez-Pacheco A; Diaz-Hernandez M; Arribas-Blázquez M; Sanz-Rodriguez A; Olivos-Oré LA; Artalejo AR; Alves M; Letavic M; Miras-Portugal MT; Conroy RM; Delanty N; Farrell MA; O'Brien DF; Bhattacharya A; Engel T; Henshall DC
    J Neurosci; 2016 Jun; 36(22):5920-32. PubMed ID: 27251615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. More than a drug target: Purinergic signalling as a source for diagnostic tools in epilepsy.
    Wong ZW; Engel T
    Neuropharmacology; 2023 Jan; 222():109303. PubMed ID: 36309046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The P2X7 Receptor as a Mechanistic Biomarker for Epilepsy.
    Engel T
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATP induces contraction of cultured brain capillary pericytes via activation of P2Y-type purinergic receptors.
    Hørlyck S; Cai C; Helms HCC; Lauritzen M; Brodin B
    Am J Physiol Heart Circ Physiol; 2021 Feb; 320(2):H699-H712. PubMed ID: 33306443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional expression of ionotropic purinergic receptors on mouse taste bud cells.
    Hayato R; Ohtubo Y; Yoshii K
    J Physiol; 2007 Oct; 584(Pt 2):473-88. PubMed ID: 17702819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P2 receptors for extracellular nucleotides in the central nervous system: role of P2X7 and P2Y₂ receptor interactions in neuroinflammation.
    Weisman GA; Camden JM; Peterson TS; Ajit D; Woods LT; Erb L
    Mol Neurobiol; 2012 Aug; 46(1):96-113. PubMed ID: 22467178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.